Brief: FDA Warns Health Care Professionals Not To Use Epinephrine Nasal Solutions From BPI Labs And Endo USA

Endo

16/01/2025 20:58

Jan 16 (Reuters) - FDA:
    * FDA: WARNS HEALTH CARE PROFESSIONALS NOT TO USE
EPINEPHRINE
NASAL SOLUTIONS FROM BPI LABS AND ENDO USA - WEBSITE
    * FDA: BPI LABS & ENDO USA NASAL SOLUTIONS PRODUCTS SHOULD
NEVER
BE INJECTED INTRAVENOUSLY
    * FDA: WARNING HEALTH CARE PROFESSIONALS NOT TO USE
UNAPPROVED
EPINEPHRINE NASAL SOLUTIONS MANUFACTURED BY BPI LABS & ENDO USA

Further company coverage:  NDOI.PK 

 ((Reuters.Briefs@thomsonreuters.com;))